Applied Biosciences Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '19 Dec 31, 2019	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Revenue	0.86	0.71	0.2	0.05	-
Revenue Growth (YoY)	75.29%	257.91%	333.67%	-	-
Cost of Revenue	0.33	0.52	0.16	0.01	-
Gross Profit	0.53	0.19	0.04	0.04	-
Selling, General & Admin	3.05	2.79	1.31	0.16	0.1
Operating Expenses	3.21	2.83	1.54	0.18	0.1
Operating Income	-2.68	-2.65	-1.49	-0.14	-0.1
Interest Expense	-0.23	-0.65	-	-	-
Interest & Investment Income	0.19	0.19	-	-	-
EBT Excluding Unusual Items	-2.76	-3.11	-1.49	-0.14	-0.1
Merger & Restructuring Charges	-	-	-	-0.38	-
Gain (Loss) on Sale of Investments	-0.3	0.43	-	-	-
Asset Writedown	-	-	-0.89	-	-
Pretax Income	-3.06	-2.68	-2.39	-0.52	-0.1
Earnings From Continuing Operations	-3.06	-2.68	-2.39	-0.52	-0.1
Minority Interest in Earnings	0.27	0.05	0.01	-0	-
Net Income	-2.79	-2.63	-2.38	-0.52	-0.1
Net Income to Common	-2.79	-2.63	-2.38	-0.52	-0.1
Shares Outstanding (Basic)	14	12	15	12	10
Shares Outstanding (Diluted)	14	12	15	12	10
Shares Change (YoY)	15.86%	-20.95%	25.11%	19.39%	-
EPS (Basic)	-0.20	-0.22	-0.16	-0.04	-
EPS (Diluted)	-0.20	-0.22	-0.16	-0.04	-
Free Cash Flow	-0.94	-0.91	-0.68	-0.14	-0.07
Free Cash Flow Per Share	-0.07	-0.08	-0.04	-0.01	-0.01
Gross Margin	61.44%	26.21%	21.26%	85.97%	-
Operating Margin	-311.94%	-374.27%	-755.84%	-306.35%	-
Profit Margin	-324.08%	-371.87%	-1202.76%	-1136.36%	-
Free Cash Flow Margin	-108.79%	-128.22%	-343.28%	-301.76%	-
EBITDA	-2.52	-2.61	-1.27	-0.12	-
EBITDA Margin	-293.27%	-	-	-262.54%	-
D&A For EBITDA	0.16	0.04	0.22	0.02	-
EBIT	-2.68	-2.65	-1.49	-0.14	-0.1
Revenue as Reported	0.86	0.71	0.2	0.05	-
Advertising Expenses	-	0.54	0.16	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.